101 related articles for article (PubMed ID: 2367391)
1. [Bioequivalence of theophylline retard capsules in children and relation of metabolism to administration route].
Berdel D; Bonnacker I; Süverkrüp R; von Berg A; Buhr W
Pneumologie; 1990 Feb; 44 Suppl 1():285-6. PubMed ID: 2367391
[TBL] [Abstract][Full Text] [Related]
2. Erratic absorption of a slow-release theophylline sprinkle product.
Pedersen S; Møller-Petersen J
Pediatrics; 1984 Oct; 74(4):534-8. PubMed ID: 6483520
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
Liebke C; Niggemann B; Wahn U
Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
[TBL] [Abstract][Full Text] [Related]
5. A new sustained-release theophylline suspension for asthmatic children: evaluation of serum theophylline concentrations.
Boner AL; Vallone G; Valletta E; Bernocchi D; Plebani M
Int J Clin Pharmacol Res; 1987; 7(5):345-50. PubMed ID: 3667007
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of salivary with serum levels of retard theophylline under steady-state conditions].
Virchow C; Schmitz-Schumann M; Mansfeld J
Pneumologie; 1990 Feb; 44 Suppl 1():281-2. PubMed ID: 2367390
[TBL] [Abstract][Full Text] [Related]
7. [Compliance of children with bronchial asthma in long-term therapy with theophylline retard preparations].
Köhler E; Sollich V; Schuster R
Kinderarztl Prax; 1993 Aug; 61(6):207-10. PubMed ID: 8411846
[TBL] [Abstract][Full Text] [Related]
8. Reliability of salivary theophylline concentration monitoring in children with bronchial asthma following the administration of different drug formulations.
Boner AL; Valletta EA; Plebani M; Biancotto R; Bellanti JA
Allergol Immunopathol (Madr); 1985; 13(5):393-8. PubMed ID: 4083233
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
[TBL] [Abstract][Full Text] [Related]
10. HPLC analysis of theophylline: bioequivalence study of two sustained-release formulations at steady state.
Mazzei M; Sottofattori E; Balbi A; Bottino GB
Farmaco; 1992 May; 47(5 Suppl):769-77. PubMed ID: 1524625
[TBL] [Abstract][Full Text] [Related]
11. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of sustained-release theophylline granules in apple sauce in pediatric asthmatic patients.
Lotner GZ; Vanderpool GE; Carroll S; Tinkelman DG; Spangler DL
Ann Allergy; 1983 Jan; 50(1):27-9. PubMed ID: 6849516
[TBL] [Abstract][Full Text] [Related]
13. [Initial experiences with "Oranienburg" slow-release theophylline in asthma therapy of children and adolescents].
Sollich V; Schuster R; Thal W; Köhler E; Walther H
Kinderarztl Prax; 1990 Jan; 58(1):45-8. PubMed ID: 2332947
[TBL] [Abstract][Full Text] [Related]
14. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
[TBL] [Abstract][Full Text] [Related]
15. [Gastrointestinal absorption of theophylline, especially with reference to retard preparations].
Rameis H; Pötzi R; Kutscher R
Z Gastroenterol; 1991 Jan; 29(1):1-5. PubMed ID: 2058222
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
van der Vet AP; Drost RH; Kreukniet J; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of a new slow-release theophylline preparation in asthmatic children].
Nieto A; Mazón A; Caballero L; Gil MC
An Esp Pediatr; 1985 Apr; 22(5):383-92. PubMed ID: 4014892
[TBL] [Abstract][Full Text] [Related]
18. [Slow-release theophylline for the treatment of asthmatic children].
Iwasaki E; Baba M
Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962
[TBL] [Abstract][Full Text] [Related]
19. [Continuous treatment of asthma in children with theophylline retard].
de Blic J; Scheinmann P; Benoist MR; Ruff F; Paupe J
Arch Fr Pediatr; 1983 Feb; 40(2):123-7. PubMed ID: 6870478
[TBL] [Abstract][Full Text] [Related]
20. [Monitoring of three delayed-release preparations of theophylline in the plasma of children: pharmacokinetic parameters and therapeutic significance].
Domínguez Granados R; Pita Calandre E; Girón Caro F; Gómez Rubio M; Molina Font JA
An Esp Pediatr; 1987 Nov; 27(5):357-61. PubMed ID: 3439657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
